Dillon & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-3,715
| Closed | -$215K | – | 79 |
|
2023
Q3 | $215K | Sell |
3,715
-75
| -2% | -$4.34K | 0.04% | 76 |
|
2023
Q2 | $243K | Sell |
3,790
-15
| -0.4% | -$962 | 0.04% | 74 |
|
2023
Q1 | $263K | Hold |
3,805
| – | – | 0.05% | 72 |
|
2022
Q4 | $274K | Sell |
3,805
-150
| -4% | -$10.8K | 0.06% | 67 |
|
2022
Q3 | $281K | Hold |
3,955
| – | – | 0.07% | 64 |
|
2022
Q2 | $305K | Hold |
3,955
| – | – | 0.07% | 62 |
|
2022
Q1 | $289K | Hold |
3,955
| – | – | 0.05% | 63 |
|
2021
Q4 | $245K | Sell |
3,955
-463
| -10% | -$28.7K | 0.04% | 69 |
|
2021
Q3 | $261K | Sell |
4,418
-9
| -0.2% | -$532 | 0.05% | 63 |
|
2021
Q2 | $297K | Sell |
4,427
-1,180
| -21% | -$79.2K | 0.06% | 61 |
|
2021
Q1 | $353K | Sell |
5,607
-51
| -0.9% | -$3.21K | 0.08% | 59 |
|
2020
Q4 | $351K | Buy |
5,658
+51
| +0.9% | +$3.16K | 0.08% | 56 |
|
2020
Q3 | $336K | Sell |
5,607
-77
| -1% | -$4.61K | 0.08% | 55 |
|
2020
Q2 | $335K | Hold |
5,684
| – | – | 0.09% | 56 |
|
2020
Q1 | $318K | Hold |
5,684
| – | – | 0.11% | 55 |
|
2019
Q4 | $364K | Buy |
+5,684
| New | +$364K | 0.1% | 56 |
|
2019
Q1 | – | Sell |
-4,090
| Closed | -$213K | – | 67 |
|
2018
Q4 | $213K | Sell |
4,090
-1,150
| -22% | -$59.9K | 0.08% | 62 |
|
2018
Q3 | $325K | Sell |
5,240
-515
| -9% | -$31.9K | 0.11% | 59 |
|
2018
Q2 | $317K | Buy |
5,755
+1,000
| +21% | +$55.1K | 0.12% | 59 |
|
2018
Q1 | $300K | Sell |
4,755
-10
| -0.2% | -$631 | 0.12% | 60 |
|
2017
Q4 | $291K | Buy |
4,765
+540
| +13% | +$33K | 0.11% | 61 |
|
2017
Q3 | $270K | Hold |
4,225
| – | – | 0.11% | 61 |
|
2017
Q2 | $237K | Hold |
4,225
| – | – | 0.1% | 67 |
|
2017
Q1 | $228K | Buy |
4,225
+275
| +7% | +$14.8K | 0.1% | 67 |
|
2016
Q4 | $229K | Buy |
+3,950
| New | +$229K | 0.1% | 66 |
|